3Greene HL,Roden DM,Katz RJ,Woosley RL,Salerno DM,Henthorn RW.The Cardiac Arrhythmia Suppression Trial:first CAST then CAST II[J].J Am Coll Carciol,1992,19∶894-898.
4Podrid PJ.Amiodarone:reevaluation of an old drug[J].Ann Intern Med,1995,122∶689-700.
5Roden DM.Pharmacokinetics of amiodarone:implications for drug therapy[J].Am J Cardiol,1993,72∶45F-50F.
6Singh BN,Venkatesh N,Nademanee K,et al.The historical development,cellular electrophysiology,and pharmacology of amiodarone[J].Prog Cardovasc D S,1989,31∶249-280.
7Singh BN,Nademanee K.Amiodarone and thyroid function:clirical implications during antiarrhythmic therapy[J].Am Heart J,1983,106∶857-869.
8Nattle S.Comparative mechanisms of action of antiarrhythmic drugs[J].Am J Cardiol,1993,72(16)∶13F-17F.
9The CASCADE investigators:The Cascade study-randomized anti-arrhythmic drug therapy in survivors of cardiac arrest in Seattle[J].Am J Cardiol,1993,13∶442-449.
10Levine JH,Massumi A,Scheinman MM,et al.Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias.The Intravenous Amiodarone Multicenter Trial Group[J].J Am Coll Cardiol,1996,27∶67-75.
